Search the collection

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 21
ArticlesPeer ReviewedFull Text
Exacerbation of Diabetic Retinopathy by Hypertension May Be Mediated by Stretch-Induced VEGFR2/KDR Expression
Author / Creator:AIELLO, LLOYD PAUL ; SUZUMA, IZUMI ; HATA, YASUAKI ; ROOK, SUSAN ; SUZUMA, KIYOSHI ; FEENER, EDWARD
Publisher:American Diabetes Association
Journal title:Diabetes (New York, N.Y.), 2000-05, Vol.49 (5), p.A49
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 22
ArticlesFull Text
Researchers from Translational Research Institute Describe Findings in Hematopoietic Stem Cell Mobilization (HIF prolyl hydroxylase inhibitor FG-4497 enhances mouse hematopoietic stem cell mobilizatio...
Publisher:NewsRX LLC
Journal title:Stem cell week, 2019-02, p.4363
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 23
ArticlesFull Text
New Findings Reported from Xi'an Jiaotong University Describe Advances in Liposomes (Delivery of sodium morrhuate to hemangioma endothelial cells using immunoliposomes conjugated with anti-VEGFR2/KDR...
Publisher:NewsRX LLC
Journal title:Obesity, fitness, & wellness week, 2017-10, p.3467
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 24
Newsletter articlesFull Text
3SBio Signs Exclusive Patent License Agreement for Tanibirumab, an Anti-VEGFR2/KDR mAb with PharmAbcine: Tanibirumab is a novel VEGFR2-neutralizing mAb for treating cancers
Publisher:New York: PR Newswire Association LLC
Journal title:PR Newswire, 2014
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 25
Newsletter articlesFull Text
3SBio Signs Exclusive Patent License Agreement for Tanibirumab, an Anti-VEGFR2/KDR mAb with PharmAbcine
Publisher:NewsRX LLC
Journal title:Biotech Week, 2014, p.176
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 26
Newsletter articlesFull Text
Breast cancer coexpresses tumor specific VEGF-A and VEGFR2/KDR protein
Publisher:NewsRX LLC
Journal title:Angiogenesis Weekly, 2004, p.27
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 27
Newsletter articlesFull Text
Breast cancer coexpresses tumor specific VEGF-A and VEGFR2/KDR protein
Publisher:NewsRX LLC
Journal title:Biotech Week, 2004, p.325
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 28
Newsletter articlesFull Text
Breast cancer coexpresses tumor specific VEGF-A and VEGFR2/KDR protein
Publisher:NewsRX LLC
Journal title:Cancer Weekly, 2004, p.147
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 29
Newsletter articlesFull Text
Breast cancer coexpresses tumor specific VEGF-A and VEGFR2/KDR protein
Publisher:NewsRX LLC
Journal title:Health & Medicine Week, 2004, p.572
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 30
Newsletter articlesFull Text
Breast cancer coexpresses tumor specific VEGF-A and VEGFR2/KDR protein
Publisher:NewsRX LLC
Journal title:Proteomics Weekly, 2004, p.114
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 31
Newspaper ArticlesFull Text
3SBio Signs Exclusive Patent License Agreement for Tanibirumab, an Anti-VEGFR2/KDR mAb with PharmAbcine
Publisher:PR Newswire Association LLC
Journal title:PR newswire, 2014-11-18
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 32
3SBio enters license pact with PharmAbcine for developing anti-VEGFR2/KDR mAb, Tanibirumab
Publisher:Mumbai: Athena Information Solutions Pvt. Ltd
Journal title:PharmaBiz, 2014-11
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 33
ArticlesPeer ReviewedFull Text
Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma
Author / Creator:Misawa, Yuki ; Misawa, Kiyoshi ; Kawasaki, Hideya ; Imai, Atsushi ; Mochizuki, Daiki ; Ishikawa, Ryuji ; Endo, Shiori ; Mima, Masato ; Kanazawa, Takeharu ; Iwashita, Toshihide ; Mineta, Hiroyuki
Publisher:London, England: SAGE Publications
Journal title:Tumor biology, 2017-07, Vol.39 (7), p.101042831771165-1010428317711657
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 34
Newsletter articlesFull Text
INTERNATIONAL PATENT: PHARMABCINE INC. FILES APPLICATION FOR "MODIFIED ANTI-VEGFR2 (KDR) ANTIBODY AND USE THEREOF"
Publisher:Washington, D.C: HT Digital Streams Limited
Journal title:US Fed News Service, Including US State News, 2023
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 35
Newsletter articlesFull Text
World Intellectual Property Organization Releases Pharmabcine Inc's Patent Application for Fusion Protein Comprising Modified Anti-VEGFR2 (KDR) Antibody and Use Thereof
Publisher:New Delhi: Pedia Content Solutions Pvt. Ltd
Journal title:Global IP News. Pharmaceutical Patent News, 2024
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 36
Newsletter articlesFull Text
INTERNATIONAL PATENT: PHARMABCINE INC., 주식회사 파멥신 FILES APPLICATION FOR "FUSION PROTEIN COMPRISING MODIFIED ANTI-VEGFR2(KDR) ANTIBODY AND USE THEREOF"
Publisher:Washington, D.C: HT Digital Streams Limited
Journal title:US Fed News Service, Including US State News, 2023
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 37
ArticlesPeer ReviewedFull Text
Internalization of Vectored Liposomes in a Culture of Poorly Differentiated Tumor Cells
Author / Creator:Mel’nikov, P. A. ; Baklaushev, V. P. ; Gabashvili, A. N. ; Nukolova, N. V. ; Levinsky, A. B. ; Chehonin, V. P.
Publisher:New York: Springer US
Journal title:Bulletin of experimental biology and medicine, 2016-08, Vol.161 (4), p.593-599
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 38
Newsletter articlesFull Text
INTERNATIONAL PATENT: PHARMABCINE INC., 주식회사 파멥신 FILES APPLICATION FOR "FUSION PROTEIN COMPRISING MODIFIED ANTI-VEGFR2 (KDR) ANTIBODY AND USE THEREOF"
Publisher:Washington, D.C: HT Digital Streams Limited
Journal title:US Fed News Service, Including US State News, 2023
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 39
ArticlesFull Text
Integrin αvβ3; integrin αvβ5; VEGF; VEGF receptor 2 (VEGFR2; KDR/FLK-1)
Publisher:New York: Nature Publishing Group US
Journal title:SciBX, 2009-03, Vol.2 (12), p.484-484
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 40
ArticlesFull Text
Integrin [alpha]v[beta]3; integrin [alpha]v[beta]5; VEGF; VEGF receptor 2 (VEGFR2; KDR/FLK-1)
Publisher:London: BioCentury Inc
Journal title:SciBX, 2009-03, Vol.2 (12)
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Showing 21 to 40 of 90 results

Export record to excel

Export this record

Export record to excel

Exacerbation of Diabetic Retinopathy by Hypertension May Be Mediated by Stretch-Induced VEGFR2/KDR Expression

Export this record

Export record to excel

Researchers from Translational Research Institute Describe Findings in Hematopoietic Stem Cell Mobilization (HIF prolyl hydroxylase inhibitor FG-4497 enhances mouse hematopoietic stem cell mobilizatio...

Export this record

Export record to excel

New Findings Reported from Xi'an Jiaotong University Describe Advances in Liposomes (Delivery of sodium morrhuate to hemangioma endothelial cells using immunoliposomes conjugated with anti-VEGFR2/KDR...

Export this record

Export record to excel

3SBio Signs Exclusive Patent License Agreement for Tanibirumab, an Anti-VEGFR2/KDR mAb with PharmAbcine: Tanibirumab is a novel VEGFR2-neutralizing mAb for treating cancers

Export this record

Export record to excel

3SBio Signs Exclusive Patent License Agreement for Tanibirumab, an Anti-VEGFR2/KDR mAb with PharmAbcine

Export this record

Export record to excel

Breast cancer coexpresses tumor specific VEGF-A and VEGFR2/KDR protein

Export this record

Export record to excel

Breast cancer coexpresses tumor specific VEGF-A and VEGFR2/KDR protein

Export this record

Export record to excel

Breast cancer coexpresses tumor specific VEGF-A and VEGFR2/KDR protein

Export this record

Export record to excel

Breast cancer coexpresses tumor specific VEGF-A and VEGFR2/KDR protein

Export this record

Export record to excel

Breast cancer coexpresses tumor specific VEGF-A and VEGFR2/KDR protein

Export this record

Export record to excel

3SBio Signs Exclusive Patent License Agreement for Tanibirumab, an Anti-VEGFR2/KDR mAb with PharmAbcine

Export this record

Export record to excel

3SBio enters license pact with PharmAbcine for developing anti-VEGFR2/KDR mAb, Tanibirumab

Export this record

Export record to excel

Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma

Export this record

Export record to excel

INTERNATIONAL PATENT: PHARMABCINE INC. FILES APPLICATION FOR "MODIFIED ANTI-VEGFR2 (KDR) ANTIBODY AND USE THEREOF"

Export this record

Export record to excel

World Intellectual Property Organization Releases Pharmabcine Inc's Patent Application for Fusion Protein Comprising Modified Anti-VEGFR2 (KDR) Antibody and Use Thereof

Export this record

Export record to excel

INTERNATIONAL PATENT: PHARMABCINE INC., 주식회사 파멥신 FILES APPLICATION FOR "FUSION PROTEIN COMPRISING MODIFIED ANTI-VEGFR2(KDR) ANTIBODY AND USE THEREOF"

Export this record

Export record to excel

Internalization of Vectored Liposomes in a Culture of Poorly Differentiated Tumor Cells

Export this record

Export record to excel

INTERNATIONAL PATENT: PHARMABCINE INC., 주식회사 파멥신 FILES APPLICATION FOR "FUSION PROTEIN COMPRISING MODIFIED ANTI-VEGFR2 (KDR) ANTIBODY AND USE THEREOF"

Export this record

Export record to excel

Integrin αvβ3; integrin αvβ5; VEGF; VEGF receptor 2 (VEGFR2; KDR/FLK-1)

Export this record

Export record to excel

Integrin [alpha]v[beta]3; integrin [alpha]v[beta]5; VEGF; VEGF receptor 2 (VEGFR2; KDR/FLK-1)

Refine your search